Antony Morgan - PowerPoint PPT Presentation

1 / 35
About This Presentation
Title:

Antony Morgan

Description:

Evidence based health promotion do we ever learn - does it make a difference? ... The best care available to all- universalism ... – PowerPoint PPT presentation

Number of Views:53
Avg rating:3.0/5.0
Slides: 36
Provided by: Eig57
Category:

less

Transcript and Presenter's Notes

Title: Antony Morgan


1

Evidence based health promotion do we ever
learn - does it make a difference?
  • Antony Morgan
  • National Institute of Health and Clinical
    Excellence (NICE), England

2
Reflections on evidence based health promotion
  • 10 years of systematic reviewing what have we
    learned
  • Overcoming deficiencies the NICE Model
  • Issues for capacity building

3
What is NICE?
  • The National Institute for Health and Clinical
    Excellence (NICE) is the independent organisation
    responsible for providing national guidance on
    the promotion of good health and the prevention
    and treatment of ill health.

4
We produce guidance in three areas
  • Public health guidance on the promotion of good
    health and the prevention of ill health for those
    working in the NHS, local authorities and the
    wider public and voluntary sector
  • Health technologies guidance on the use of new
    and existing medicines, treatments and procedures
    within the NHS
  • Clinical practice guidance on the appropriate
    treatment and care of people with specific
    diseases and conditions within the NHS.

5
Archie Cochranes Principles (1979)
  • The best care available to all- universalism
  • The need for a means to determine what was
    best-empirical
  • The importance of rooting out harmful or useless
    practice-compassion
  • The necessity of ascertaining costs and
    benefits-accountability

6
The legacy
  • The Cochrane and Campbell Collaborations
  • The importance of the systematic review and meta
    analysis
  • The importance of making evidence based decisions
  • The importance of dealing with health
    inequalities

7
In the beginning
  • Health Education Authority 1997-2000
  • First series of systematic reviews in England to
    prove the worth of health promotion
  • Results equivocal - more research needed.

8
An early systematic review health promotion in
young people for the prevention of substance
misuse (White and Pitts, 1997)
  • Why? In the 1990s the misuse of drugs was
    widespread in secondary schools in the UK, often
    starting as early as 13.
  • Key question to identify interventions that have
    been effective in preventing or reducing use of
    illicit substances in young people
  • Key results Current research evidence is
    inadequate to allow confident recommendations to
    plan and implement substance abuse policies for
    young people. No specific intervention programmes
    for substance misuse prevention in young people
    have been shown to be effective in the long term

9
The example continued
  • Key findings
  • interventions tend not to consider the varying
    contexts in which drug misuse occurs
  • There needs to be better understanding of what
    young people believe about drugs and their
    consequences if plausible and relevant
    interventions are to be developed.
  • Alternative evaluation strategies are needed to
    assess the impact of harm minimisation
    interventions and other programmes targeting hard
    to reach groups
  • There is a need for an assessment of which
    elements or mix of elements are most effective as
    well as an assessment of the programme as a whole

10
A systematic review, for NICE guidance -
community based drug interventions for young
people (John Moores University, 2007)
  • Why? Illicit drug use in the UK is the most
    prevalent among young people aged 16 to 24 years.
    Vulnerable young people were 5 times more likely
    to use drugs than less vulnerable peers
  • Key Question What community based interventions
    are effective and cost effective in reducing
    substance misuse among the most vulnerable and
    disadvantaged children and young people
  • Key findings
  • Almost all of the studies of interventions to
    reduce problematic substance misuse have looked
    at the effects over the short term
  • There is a lack of evidence on the specific
    components of a substance misuse intervention
    that make it effective
  • Few rigorous evaluations have been carried out in
    the UK on the effectiveness and cost
    effectiveness of community based interventions to
    reduce or prevent substance misuse.

11
How systematic reviews have disappointed
  • Not paying enough attention to the right
    questions too much on the what questions and
    not enough on the how
  • Trying to cover too much ground broad questions
    broad answers
  • And the most cynical..
  • Too much journal impact factor and not enough
    population health impact factor

12
A limited evidence base .
  • Evidence about what works to reduce inequalities
    very limited
  • Rich in description, weak on solution.
  • More on what is effective but little on how
    things can be done to improve things

13
And why?
  • Gaps in the initial formulation of primary
    research studies.
  • Gap between evidence and practice
  • Failure to distinguish between determinants of
    wellbeing and determinants of inequalities in
    well being
  • Much more focus on deficit /risk factor model
    than asset based/ resources model

14
However..
  • Still possible to produce recommendations that
    support the improvement of standards in practice
    through
  • Mix method approaches to collecting and collating
    evidence
  • Expert opinion
  • Lay knowledge
  • Stakeholder testing and validation

15
Core principles of all NICE guidance
  • Comprehensive evidence base
  • Expert input
  • Patient and carer involvement
  • Independent advisory committees
  • Genuine consultation
  • Regular review
  • Open and transparent process.

16
Developing NICE guidance key stages
  • Topic referral
  • Scoping
  • Development
  • Validation
  • Publication

17
Scoping
18
Scoping the guidance
  • Clear definition of the intervention or
    programmes
  • Background information on public health issues
    and need for guidance (including policy context)
  • Identifies key audience (s)
  • Sets out key questions.

19
Key questions
  • What is effective?
  • What is ineffective?
  • What is harmful or dangerous?

20
Areas of enquiry
  • Our reviews aim to address the following areas
    looking explicitly at evidence on variation and
    inequalities
  • Intervention aims objectives, delivery mode,
    intervener
  • Target group characteristics views
  • Setting context
  • Intensity/duration
  • Cost
  • Implementation feasibility

21
Getting the questions right review stage
  • Distinguishing between impact, process and
    experience
  • Distinguishing between audience, high level
    policy makers or local providers of services.

22
Development
23
Development reviewing the evidence
  • Extensive use of reviews and primary research
  • Rapid reviews
  • assess quality and strength of evidence
  • assess applicability
  • Economic appraisal
  • economic evaluations and modelling

24
Finding, collating and synthesising evidence
  • Broad spectrum of possibilities,
  • Quality of the research, not privileging types of
    or hierarchies of evidence
  • Ongoing consultation (expert consultations)
  • New ways of searching the literature e.g.
    evidence mapping

25
Development drafting the recommendations
  • Advisory committees (PHIAC/PDG) meet to agree
    draft recommendations
  • Expert Witnesses, Cooptees
  • Recommendations
  • strength and applicability of evidence
  • cost effectiveness
  • impact, including on inequalities in health
  • risks, benefits
  • implementability

26
Validation
27
Validation
  • Recommendations for consultation
  • Fieldwork
  • Review meeting
  • stakeholder comments on draft recommendations
  • fieldwork data
  • additional evidence
  • revise recommendations and produce guidance

28
What does the guidance look like?
  • Recommendations
  • Who is the target audience
  • Who should take action
  • What action should they take.
  • Considerations
  • Critical conditions for success, caveats
  • Gaps in research
  • Improve the evidence base next time round

29
Capacity issues whats coming next?
30
New frameworks for constructing the evidence base
work of the Measurement and Evidence Network
(Kelly et al, 2007)
  • Commitment to the value of equity (1) they
    exist between and within societies and that they
    are unfair.
  • Taking and evidence based approach (2) research
    is high quality, and relevant
  • Methodological diversity (3) appropriate
    methods, right questions
  • Gaps and gradients (4) analysis of structures
    if inequities in a given society
  • Causes, determinants and outcomes (5) social
    and biological factors interacting together.
  • Social structure (6) and social dynamics (7)
    dimensions of inequity, power structures in
    different societies the importance of context
  • Explicating bias (8) scientific, political,
    ideological making it explicit

31
Public health Review Group in Cochrane
  • 1996 Health Promotion Field (based in UK and
    Canada)
  • 1999-2006 Health Promotion and Public Health
    Field (2000 Australia)
  • 2007 Joint editing role on PH titles with EPOC
  • 2008 (mid-April) Public Health Review Group
    registered
  • Contact database 442 members, from 48 different
    countries

32
From a Field to a Public Health Review Group
  • Current Review Groups tend to address single
    interventions with straightforward outcomes not
    congruent with PH interventions and outcomes.
  • Need for a CRG to tackle the complex,
    multi-sectoral, multi-component, upstream
    interventions called for in public health
  • Ensure that high quality evidence reviews focus
    on what works for whom and why understandable
    to public health folkas well as those from other
    sectors
  • Need to engage sectors outside health (eg.
    Transport, urban planning, education etc.)

33
Commitment and challenges
  • Support for more involvement in Cochrane from
    those working in public health
  • Recruiting experienced public health reviewers to
    undertake Cochrane reviews
  • Determining and supporting the production of high
    priority reviews
  • Establishing closer ties with other public health
    organisations globally
  • Engaging with sectors outside of health (to be
    true to our upstream, multisectorial scope)
  • Potential co-registration opportunities with
    Campbell Collaboration (education, social welfare
    and criminal justice topics)

34
Key messages
  • Need to take look at the benefits and limits of
    systematic reviews in evidence based health
    promotion how far can they go to answer our key
    questions.
  • Evidence based health promotion should be about
    science policy and practice and all the processes
    in between. e.g the NICE model.
  • Need to find ways of building capacities and
    skills in new generations of health promotion
    professionals through
  • Skills development programmes that help
    professionals diversify e.g. more health
    promotion professionals doing systematic reviews
  • More person to person knowledge transfer
    inter-generational exchange

35
10 years is a relatively short time in health
promotion but it would be both depressing and
inexcusable if someone else was able to repeat
this presentation in 2018
  • Cautionary note
Write a Comment
User Comments (0)
About PowerShow.com